The Dr. Teal’s line of adult and kids’ melatonin-containing topical products includes a body scrub, bath soak, and moisturizer.
The National Advertising Division (NAD) of BBB National Programs has referred an advertising-claims case to the FTC to review. The claims were made by PDC Brands’ Dr. Teal’s brand for its adult and kids’ melatonin products.
Market competitor The Procter & Gamble Co. (P&G) initially referred the case to the NAD for review, stating that the Dr. Teal’s product claims are “unsupported and misled consumers into believing that they deliver melatonin-derived sleep benefits that consumers have become familiar with (i.e., helping them and/or their children fall asleep and stay asleep),” states an NAD press release.
According to the press release, when contacted by the NAD over its claims, the Dr. Teal’s brand said that its advertising does not attribute any specific health benefits to the melatonin ingredients in its products, which include topical products like a sleep balm, body lotion, “sleep spray,” bath soak, body balm, and a combination bubble bath, body wash, and shampoo.
In the press release, NAD lists some of the brand’s advertising claims referred to the FTC, including “Just spritz pillows and bedding with the Sleep Spray and rub the Sleep Balm on their back, chest, or feet. They’ll be dreaming in no time.” Another claim states: “The secret to a good night’s rest is Dr. Teal’s Sleep Lotion with Melatonin and Essential Oils.”
NAD says the brand’s owner, PDC Brands, declined to participate in NAD’s self-regulatory process, so NAD in turn referred the matter to FTC “for review and possible enforcement action,” the release states.
What's next for NPA and CRN in their complaints against New York state?
May 2nd 2024The latest updates in the efforts of the Natural Products Association and the Council for Responsible Nutrition to sue New York state for its law banning the sale of weight management and muscle building supplements to minors.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.